Kuros Biosciences AG (SWX:KURN)
Switzerland · Delayed Price · Currency is CHF 27.28
-0.44 (-1.59%)
At close: Dec 19, 2025
Kuros Biosciences AG Market Cap
Kuros Biosciences AG has a market cap or net worth of 1.07 billion as of December 19, 2025. Its market cap has increased by 42.14% in one year.
Market Cap
1.07B
Enterprise Value
1.05B
Revenue
103.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.28
Market Cap Chart
Since January 21, 2016, Kuros Biosciences AG's market cap has decreased from 3.25B to 1.07B, a decrease of -67.13%. That is a compound annual growth rate of -10.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 1.07B | 32.58% |
| Dec 30, 2024 | 805.64M | 527.99% |
| Dec 29, 2023 | 128.29M | 138.81% |
| Dec 30, 2022 | 53.72M | -14.90% |
| Dec 30, 2021 | 63.13M | -4.70% |
| Dec 30, 2020 | 66.24M | 20.42% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jan 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 278.18B |
| Novartis AG | 208.23B |
| Galderma Group AG | 38.65B |
| Lonza Group AG | 37.42B |
| Alcon | 31.21B |
| Sandoz Group AG | 24.95B |
| Straumann Holding AG | 15.03B |
| Sonova Holding AG | 12.29B |